The Thailand Securities and Exchange Commission has instructed DOD Biotech Public Company Limited to cooperate with its auditor and submit auditor-reviewed, rectified interim financial statements for the revised first quarter and second quarter of 2026. DOD must also disclose the statements and related report through the Stock Exchange of Thailand’s SETLink system by Oct. 14, 2026. The order follows qualified conclusions from DOD’s auditor, which still lacked sufficient appropriate evidence for the business rationale behind a deposit for mortgaged land. The auditor also lacked evidence concerning the recoverability of a difference in machinery value and the receipt of assets associated with deposits and advance payments for land, raw materials and machinery, leaving it unable to determine whether related accounts required adjustment.

Original source